tm
Seeing Is Believing
tm
Seeing Is Believing
Cue Biopharma's activity chart (see below) currently has 21 price targets and 20 ratings on display.
Analysts average stock forecasts to be materialized ratio is 84.52% with an average time for these price targets to be met of 530.17 days.
Most recent stock forecast was given by from LUCID CAPITAL on 25-Aug-2025. First documented stock forecast 21-Jan-2020.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 25-Aug-2025
$4
$-21.39 (-84.25%)
1 years 21 days ago
(25-Aug-2025)
1/1 (100%)
$3.18 (387.80%)
242
Buy Since 22-Jan-2020
$2
$-23.39 (-92.12%)
$2
1 years 5 months ago
(15-Apr-2025)
7/7 (100%)
$1.2 (150.00%)
714
Buy Since 13-Mar-2024
$4
$-21.39 (-84.25%)
$6
1 years 10 months ago
(15-Nov-2024)
2/2 (100%)
$2.75 (220.00%)
649
Buy Since 09-Apr-2020
$4
$-21.39 (-84.25%)
$8
2 years 26 days ago
(20-Aug-2024)
4/4 (100%)
$3.14 (365.12%)
700
Buy Since 21-Nov-2022
$3
$-22.39 (-88.18%)
$3
2 years 26 days ago
(20-Aug-2024)
5/5 (100%)
$2.14 (248.84%)
839
What is CUE (Cue Biopharma) average time for price targets to be met?
Which analyst most recently updated their price target on CUE (Cue Biopharma)?
Which analyst has the most public recommendations on CUE (Cue Biopharma)?
Which analyst is the currently most bullish on CUE (Cue Biopharma)?
Which analyst is the currently most reserved on CUE (Cue Biopharma)?
